Establishment Labs Holdings Inc. - Common Shares (NQ:ESTA)

62.46 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Establishment Labs Holdings Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

Establishment Labs (ESTA) Q3 2026 Earnings Call Transcript ↗

October 29, 2026

Revenue surged 33.9% as company hit first positive free cash flow quarter.

Via The Motley Fool

Topics Earnings

What Establishment Labs (ESTA) Said on Its Q3 Earnings Call ↗

October 29, 2026

Establishment Labs (NASDAQ:ESTA) reported third-quarter revenue growth of 33.9% year over year to $72 million, driven by U.S. market-share gains and expansion across international markets, while the...

Via MarketBeat

Topics Earnings

Establishment Labs® Reports Third Quarter 2026 Financial Results

October 29, 2026

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29

October 19, 2026

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs Holdings (NASDAQ:ESTA) Meets Minervini Trend Template and High Growth Momentum Criteria ↗

July 07, 2026

Via Chartmill

Establishment Labs Holdings (NASDAQ:ESTA) Beats Revenue Estimates and Raises Full-Year Guidance in Q1 2026 Earnings ↗

May 06, 2026

Via Chartmill

Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®

October 05, 2026

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants

September 21, 2026

From Establishment Labs Holdings Inc.

Via Business Wire

The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For

August 12, 2026

News Provided by USA News Group on behalf of Conexeu Sciences Inc.

From USA News Group

Via GlobeNewswire

Establishment Labs Q2 Earnings Call Highlights ↗

August 06, 2026

Establishment Labs (NASDAQ:ESTA) reported second-quarter revenue growth of 31.7% year over year, driven by continued rapid expansion in the United States, rising adoption of its Minimally Invasive...

Via MarketBeat

Topics Earnings

Establishment Labs® Reports Second Quarter 2026 Financial Results

August 06, 2026

From Establishment Labs Holdings Inc.

Via Business Wire

Jim Cramer: Bending Spoons Is A ‘Really Good’ Software Company, Recommends Buying This Industrial Stock ↗

July 31, 2026

Jim Cramer recommends buying Howmet Aerospace Inc. (NYSE: HWM) and Farmers National Banc Corp. (NASDAQ: FMNB), and says Bending Spoons S.p.A. (NASDAQ: BSP) is a good software company. He is not a fan...

Via Benzinga

Establishment Labs® to Announce Second Quarter 2026 Financial Results on August 6

July 23, 2026

From Establishment Labs Holdings Inc.

Via Business Wire

A Hedge Fund Dumped Establishment Labs Shares Worth $6.6 Million. Here's a Closer Look at the Transaction. ↗

July 05, 2026

This global medical device innovator, known for advanced breast implant systems, reported a notable insider sale in recent filings.

Via The Motley Fool

Topics Regulatory Compliance

A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity

July 01, 2026

From Biotech Insider

Via GlobeNewswire

Establishment Labs® Appoints Taylor Harris to Board of Directors

June 29, 2026

From Establishment Labs Holdings Inc.

Via Business Wire

The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It

June 25, 2026

From Biotech Insider

Via GlobeNewswire

Establishment Labs® Added to Membership of U.S. Small-Cap Russell 2000® Index

June 25, 2026

From Establishment Labs Holdings Inc.

Via Business Wire

Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy? ↗

May 30, 2026

Establishment Labs develops advanced silicone implants and medical devices for global plastic surgery markets.

Via The Motley Fool

Topics Regulatory Compliance

After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead

May 27, 2026

Issued on behalf of Conexeu Sciences Inc.

From Biotech Insider

Via GlobeNewswire

The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself

May 22, 2026

From Energy Metal News

Via GlobeNewswire

Route 92 Medical Announces Appointment of Raj Denhoy as Chief Financial Officer

May 18, 2026

From Route 92 Medical, Inc.

Via GlobeNewswire

Core Natural Resources Stock Trails the Market, but One Fund Is Buying Up Shares ↗

May 14, 2026

This U.S.-based coal producer operates integrated mining and export facilities, supplying power generators and industrial clients worldwide.

Via The Motley Fool

Topics Regulatory Compliance

What to Know About This Fund’s $23 Million Appian Buy Amid AI Automation Growth and a 40% Stock Drop ↗

May 14, 2026

Appian provides low-code automation tools for enterprise clients, enabling rapid digital transformation across multiple industries.

Via The Motley Fool

Topics Artificial Intelligence Regulatory Compliance

Warrior Met Coal Stock Has Soared 80%. One Investor Just Trimmed $32 Million ↗

May 14, 2026

Warrior Met Coal supplies metallurgical coal to global steelmakers, operating two underground mines in Alabama for export markets.

Via The Motley Fool

Topics Energy Regulatory Compliance Supply Chain

ESTA Founder Sells $7.9M on Earnings Day — Here's Why that's Not the Story ↗

May 11, 2026

This global medtech firm specializing in advanced implant solutions reported a notable insider sale amid a year of strong share performance.

Via The Motley Fool

Topics Regulatory Compliance

This Biotech Stock Has Soared 175%. Here’s Why One Fund Still Sold $3 Million Worth ↗

May 09, 2026

This biotech firm develops therapies for rare pulmonary diseases, leveraging proprietary drug delivery technology in the U.S. market.

Via The Motley Fool

Topics Regulatory Compliance

ESTA Q1 2026 Earnings Transcript ↗

May 07, 2026

ESTA Q1 2026 Earnings Transcript

Via The Motley Fool

Establishment Labs Reports First Quarter 2026 Financial Results

May 06, 2026

From Establishment Labs Holdings Inc.

Via Business Wire

Establishment Labs® Refinances Credit Facility

April 30, 2026

From Establishment Labs Holdings Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.